FMO5 and Hyperglycemia: Recent reports suggest that hyperglycemia leads to metabolic reprograming, characterized by excessive glycolysis and pentose phosphate pathway (PPP), and subsequent elevated levels of metabolites which feeds into neutrophil functions such as activation of NADPH-oxidase and production of ROS (53).